Gout Disease Control Suffered After FDA-Driven Price Hike: Study

A study out Tuesday found the price of the gout drug colchicine increased significantly in the last decade due to an FDA policy decision in 2010, leading to lower use and poorer disease control.

The research showed that the large increase in the price of colchicine in 2010 was associated with an immediate decrease in its use, according to research published in the Journal of the American Medical Association.